Patient Engagement And Coaching for Health: an intensive treatment intervention for patients with type 2 diabetes in communities

Completed

• Conditions: Type 2 diabetes with HbA1C >7.5% in the last 12 months; Nutritional, Metabolic, Endocrine; Diabetes

• Registration Number: ISRCTN50662837
• Lead Sponsor: ational Health and Medical Research Council (Australia)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-07-14
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 336

Inclusion Criteria

Current inclusion criteria as of 06/02/2009:
1. General practices will be included in the study if practices are computerised
2. >50% of Practice GPs agree to participate and to be randomised to intervention or control group
3. GPs are willing to search their medical records and pathology database with assistance from research team and be willing to recruit patients with T2D from their practices in accordance with privacy and ethical guidelines
4. Patients with T2D will be invited to participate if they are >18 years with haemoglobin HbA1c (HbA1c) >7.5% and receiving care from general practices in the northern or northwest region of Melbourne that employ a practice nurse.

Previous inclusion criteria:
1. General practices will be included in the study if practices are computerised
2. >50% of Practice GPs agree to participate and to be randomised to intervention or control group
3. GPs are willing to search their medical records database with assistance from research team and be willing to recruit patients with T2D from their practices in accordance with privacy and ethical guidelines
4. Patients with T2D will be invited to participate if they are >18 years with haemoglobin HbA1c (HbA1c) >7.5% and receiving care from general practices in the northern or northwest region of Melbourne that employ a practice nurse.

Exclusion Criteria

1. Patients will be excluded if they are not contactable by telephone
2. Patients having a complex debilitating coexisting medical condition e.g. mental illness, end-stage cancer
3. Patients who do not provide signed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified